Attention-deficit hyperactivity disorder (ADHD) is characterized by inattention, hyperactivity and impulsivity leading to difficulties at home, education and daily activities. ADHD remains relatively young within paediatric psychiatry with its recognition and management developing over the last 20 years. A consensus towards diagnosis and management has come with recent NICE guidelines.
JensenP.3-Year follow-up of the NIMH MTA study. Journal of the American Academy of Child and Adolescent Psychiatry (2007) 46 (8): p. 989–1002
5.
KeenD.Attention deficit hyperactivity disorder — how much do we see?. Child Psychology and Psychiatry Review (2000) 5 (4): p. 164–8
6.
KonofalE.Iron deficiency in children with attention-deficit/hyperactivity disorder. Archives of Paediatric and Adolescent Medicine (2004) 158: p. 1113–5 Accessed via archpedi.ama-assn.org/cgi/reprint/158/12/1113 [date last accessed 12.03.2009]
NICEAttention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults (2008) Accessed via www.nice.org.uk/nicemedia/pdf/CG072NiceGuidelineV2.pdf [date last accessed 12.03.2009]
9.
NICEMethylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Technology Appraisal98 (2006) Accessed via www.nice.org.uk/nicemedia/pdf/TA098guidance.pdf [date last accessed 12.03.2009]
The MTA Cooperative Group A 14-month randomized clinical trial of treatment strategies for attention-deficit hyperactivity disorder. Archives of General Psychiatry (1999) 56: p. 1073–86
